Baird Financial Group’s Regeneron Pharmaceuticals REGN Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2025
Q2
$25.7M Buy
48,979
+4,383
+10% +$2.3M 0.05% 310
2025
Q1
$28.3M Buy
44,596
+9,883
+28% +$6.27M 0.05% 273
2024
Q4
$24.7M Sell
34,713
-1,135
-3% -$808K 0.05% 299
2024
Q3
$37.7M Buy
35,848
+1,155
+3% +$1.21M 0.07% 238
2024
Q2
$36.5M Buy
34,693
+761
+2% +$800K 0.08% 238
2024
Q1
$32.7M Buy
33,932
+71
+0.2% +$68.3K 0.07% 249
2023
Q4
$29.7M Buy
33,861
+255
+0.8% +$224K 0.07% 252
2023
Q3
$27.7M Buy
33,606
+295
+0.9% +$243K 0.08% 233
2023
Q2
$23.9M Buy
33,311
+1,885
+6% +$1.35M 0.06% 264
2023
Q1
$25.8M Sell
31,426
-4,064
-11% -$3.34M 0.06% 266
2022
Q4
$25.6M Sell
35,490
-24
-0.1% -$17.3K 0.07% 264
2022
Q3
$24.5M Sell
35,514
-1,481
-4% -$1.02M 0.07% 255
2022
Q2
$21.9M Buy
36,995
+466
+1% +$275K 0.06% 289
2022
Q1
$25.5M Buy
36,529
+18,345
+101% +$12.8M 0.06% 273
2021
Q4
$11.5M Sell
18,184
-1,116
-6% -$705K 0.03% 408
2021
Q3
$11.7M Buy
19,300
+4,073
+27% +$2.46M 0.03% 391
2021
Q2
$8.51M Buy
15,227
+2,458
+19% +$1.37M 0.02% 459
2021
Q1
$6.04M Buy
12,769
+4,293
+51% +$2.03M 0.02% 524
2020
Q4
$4.1M Buy
8,476
+439
+5% +$212K 0.01% 601
2020
Q3
$4.5M Buy
8,037
+310
+4% +$173K 0.02% 513
2020
Q2
$2.13M Sell
7,727
-339
-4% -$93.5K 0.01% 709
2020
Q1
$3.94M Sell
8,066
-2,033
-20% -$993K 0.02% 498
2019
Q4
$3.79M Sell
10,099
-3,169
-24% -$1.19M 0.01% 597
2019
Q3
$1.34M Sell
13,268
-8,199
-38% -$826K 0.01% 900
2019
Q2
$6.72M Buy
21,467
+4,766
+29% +$1.49M 0.03% 440
2019
Q1
$6.86M Sell
16,701
-412
-2% -$169K 0.04% 377
2018
Q4
$6.39M Sell
17,113
-317
-2% -$118K 0.04% 375
2018
Q3
$6.94M Sell
17,430
-396
-2% -$158K 0.04% 381
2018
Q2
$6.15M Buy
17,826
+779
+5% +$269K 0.04% 386
2018
Q1
$5.87M Buy
17,047
+1,297
+8% +$447K 0.04% 393
2017
Q4
$5.92M Buy
15,750
+2,122
+16% +$798K 0.04% 390
2017
Q3
$6.09M Sell
13,628
-4,018
-23% -$1.8M 0.05% 379
2017
Q2
$8.67M Buy
17,646
+610
+4% +$300K 0.07% 284
2017
Q1
$6.6M Sell
17,036
-108
-0.6% -$41.8K 0.05% 341
2016
Q4
$6.29M Buy
17,144
+221
+1% +$81.1K 0.05% 324
2016
Q3
$6.8M Sell
16,923
-4,473
-21% -$1.8M 0.06% 314
2016
Q2
$7.48M Buy
21,396
+686
+3% +$240K 0.07% 289
2016
Q1
$7.47M Buy
20,710
+4,116
+25% +$1.48M 0.07% 272
2015
Q4
$9.01M Buy
16,594
+1,834
+12% +$996K 0.09% 235
2015
Q3
$6.87M Sell
14,760
-8
-0.1% -$3.72K 0.07% 270
2015
Q2
$7.53M Buy
+14,768
New +$7.53M 0.07% 257